Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $8.4500 (-3.7%) ($8.4500 - $8.4500) on Tue. May. 16, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.48% (three month average) | RSI | 67 | Latest Price | $8.4500(-3.7%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -0.4% a day on average for past five trading days. | Weekly Trend | BCRX advances 6% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) ARKG(29%) XLRE(28%) SDY(26%) BND(25%) CEMB(25%) | Factors Impacting BCRX price | BCRX will decline at least -1.74% in a week (0% probabilities). VIXM(-25%) VXX(-24%) TLT(-15%) VCIT(-11%) LQD(-10%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.74% (StdDev 3.48%) | Hourly BBV | -0.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $8.52(-0.82%) | 10 Day Moving Average | $8.5(-0.59%) | 20 Day Moving Average | $8.02(5.36%) | To recent high | -16.6% | To recent low | 14.6% | Market Cap | $1.491b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |